ALTIRIS THERAPEUTICS has a total of 13 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Australia, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SHANGHAI YIZHI MEDICINE TECHNOLOGY CO LTD, MARVEL LIFESCIENCES LTD and KADOR PETER F.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | New Zealand | 1 | |
#10 | Singapore | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Skudlarek Jason W | 12 |
#2 | Natchus Michael G | 12 |
#3 | Clark Michael P | 12 |
#4 | Johnson Tricia L | 12 |
#5 | Lockwood Mark A | 12 |
#6 | Doroh Brandon C | 12 |
#7 | Wagner Florence F | 12 |
#8 | Wiseman John M | 12 |
#9 | Wilson Lawrence | 11 |
#10 | Tahirovic Yesim Altas | 11 |
Publication | Filing date | Title |
---|---|---|
AU2013203978A1 | Chemokine receptor modulators | |
BRPI0909375A2 | Chemokine Receptor Modulators |